Form D · Other Health Care

MIRAMAR LABS, INC.

Santa Clara, CA · CIK 0001586727

Offering snapshot reported Feb 9, 2017 · SEC filing

Reported sold
$2.46M
Offering amount: $3M
Investors reported
3
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 27, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 9, 2017Initial$2,464,735No comparison3SEC filing
Aug 5, 2016Amendment$9,571,815$194,400vs Jul 13, 201627SEC filing
Jul 13, 2016Amendment$9,377,415$279,115vs Jun 21, 201620SEC filing
Jun 21, 2016Initial$33,575,527No comparison36SEC filing
Jun 21, 2016Initial$9,098,300No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-280384

Source: Form D, filed Feb 9, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Deem Director
Brian H. Dovey Director
Hanson Gifford Iii Director
Maxim Gorbachev Director
Steven Kim Executive
R. Michael Kleine Director, Executive
Brigid Makes Executive
Henry Plain, Jr. Director
Stacey Seltzer Director
Patrick F. Williams Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2790 Walsh Avenue
Santa Clara, CA, 95051